Cargando…
Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides
BACKGROUND: Flavonoids are bio-active specialized plant metabolites which mainly occur as different glycosides. Due to the increasing market demand, various biotechnological approaches have been developed which use Escherichia coli as a microbial catalyst for the stereospecific glycosylation of flav...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573293/ https://www.ncbi.nlm.nih.gov/pubmed/26377568 http://dx.doi.org/10.1186/s12934-015-0326-1 |
_version_ | 1782390467676078080 |
---|---|
author | De Bruyn, Frederik Van Brempt, Maarten Maertens, Jo Van Bellegem, Wouter Duchi, Dries De Mey, Marjan |
author_facet | De Bruyn, Frederik Van Brempt, Maarten Maertens, Jo Van Bellegem, Wouter Duchi, Dries De Mey, Marjan |
author_sort | De Bruyn, Frederik |
collection | PubMed |
description | BACKGROUND: Flavonoids are bio-active specialized plant metabolites which mainly occur as different glycosides. Due to the increasing market demand, various biotechnological approaches have been developed which use Escherichia coli as a microbial catalyst for the stereospecific glycosylation of flavonoids. Despite these efforts, most processes still display low production rates and titers, which render them unsuitable for large-scale applications. RESULTS: In this contribution, we expanded a previously developed in vivo glucosylation platform in E. coli W, into an efficient system for selective galactosylation and rhamnosylation. The rational of the novel metabolic engineering strategy constitutes of the introduction of an alternative sucrose metabolism in the form of a sucrose phosphorylase, which cleaves sucrose into fructose and glucose 1-phosphate as precursor for UDP-glucose. To preserve these intermediates for glycosylation purposes, metabolization reactions were knocked-out. Due to the pivotal role of UDP-glucose, overexpression of the interconverting enzymes galE and MUM4 ensured the formation of both UDP-galactose and UDP-rhamnose, respectively. By additionally supplying exogenously fed quercetin and overexpressing a flavonol galactosyltransferase (F3GT) or a rhamnosyltransferase (RhaGT), 0.94 g/L hyperoside (quercetin 3-O-galactoside) and 1.12 g/L quercitrin (quercetin 3-O-rhamnoside) could be produced, respectively. In addition, both strains showed activity towards other promising dietary flavonols like kaempferol, fisetin, morin and myricetin. CONCLUSIONS: Two E. coli W mutants were engineered that could effectively produce the bio-active flavonol glycosides hyperoside and quercitrin starting from the cheap substrates sucrose and quercetin. This novel fermentation-based glycosylation strategy will allow the economically viable production of various glycosides. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-015-0326-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4573293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45732932015-09-18 Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides De Bruyn, Frederik Van Brempt, Maarten Maertens, Jo Van Bellegem, Wouter Duchi, Dries De Mey, Marjan Microb Cell Fact Research BACKGROUND: Flavonoids are bio-active specialized plant metabolites which mainly occur as different glycosides. Due to the increasing market demand, various biotechnological approaches have been developed which use Escherichia coli as a microbial catalyst for the stereospecific glycosylation of flavonoids. Despite these efforts, most processes still display low production rates and titers, which render them unsuitable for large-scale applications. RESULTS: In this contribution, we expanded a previously developed in vivo glucosylation platform in E. coli W, into an efficient system for selective galactosylation and rhamnosylation. The rational of the novel metabolic engineering strategy constitutes of the introduction of an alternative sucrose metabolism in the form of a sucrose phosphorylase, which cleaves sucrose into fructose and glucose 1-phosphate as precursor for UDP-glucose. To preserve these intermediates for glycosylation purposes, metabolization reactions were knocked-out. Due to the pivotal role of UDP-glucose, overexpression of the interconverting enzymes galE and MUM4 ensured the formation of both UDP-galactose and UDP-rhamnose, respectively. By additionally supplying exogenously fed quercetin and overexpressing a flavonol galactosyltransferase (F3GT) or a rhamnosyltransferase (RhaGT), 0.94 g/L hyperoside (quercetin 3-O-galactoside) and 1.12 g/L quercitrin (quercetin 3-O-rhamnoside) could be produced, respectively. In addition, both strains showed activity towards other promising dietary flavonols like kaempferol, fisetin, morin and myricetin. CONCLUSIONS: Two E. coli W mutants were engineered that could effectively produce the bio-active flavonol glycosides hyperoside and quercitrin starting from the cheap substrates sucrose and quercetin. This novel fermentation-based glycosylation strategy will allow the economically viable production of various glycosides. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-015-0326-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-16 /pmc/articles/PMC4573293/ /pubmed/26377568 http://dx.doi.org/10.1186/s12934-015-0326-1 Text en © De Bruyn et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research De Bruyn, Frederik Van Brempt, Maarten Maertens, Jo Van Bellegem, Wouter Duchi, Dries De Mey, Marjan Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides |
title | Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides |
title_full | Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides |
title_fullStr | Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides |
title_full_unstemmed | Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides |
title_short | Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides |
title_sort | metabolic engineering of escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573293/ https://www.ncbi.nlm.nih.gov/pubmed/26377568 http://dx.doi.org/10.1186/s12934-015-0326-1 |
work_keys_str_mv | AT debruynfrederik metabolicengineeringofescherichiacoliintoaversatileglycosylationplatformproductionofbioactivequercetinglycosides AT vanbremptmaarten metabolicengineeringofescherichiacoliintoaversatileglycosylationplatformproductionofbioactivequercetinglycosides AT maertensjo metabolicengineeringofescherichiacoliintoaversatileglycosylationplatformproductionofbioactivequercetinglycosides AT vanbellegemwouter metabolicengineeringofescherichiacoliintoaversatileglycosylationplatformproductionofbioactivequercetinglycosides AT duchidries metabolicengineeringofescherichiacoliintoaversatileglycosylationplatformproductionofbioactivequercetinglycosides AT demeymarjan metabolicengineeringofescherichiacoliintoaversatileglycosylationplatformproductionofbioactivequercetinglycosides |